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Colorectal cancer is the fourth most commonly diagnosed cancer and the second leading cause of cancer-related death 
in Wisconsin. Incidence and mortality rates for colorectal cancer vary by age, race/ethnicity, geography, and 
socioeconomic status. From 2010 through 2012, the Wisconsin Comprehensive Cancer Control Program awarded 
grants to 5 regional health systems for the purpose of planning and implementing events to increase colorectal cancer 
screening rates in underserved communities.
Community Context
Grantees were chosen for their ability to engage community partners in reaching underserved groups including African 
American, Hispanic/Latino, Hmong, rural, and uninsured populations in their service areas.
Methods
Grantees identified target populations for proposed screening events, designated institutional planning teams, engaged 
appropriate local partner organizations, and created plans for follow-up. All grantees implemented 1 or more colorectal 
cancer screening events within 6 months of receiving their awards. Events were conducted in 2 phases.
Outcomes
Participating health systems organized 36 screening events and distributed 633 individual test kits; 506 kits were 
returned, of which 57 (9%) tested positive for colorectal abnormalities. Of attendees who received screening, 63% were 
uninsured or underinsured, 55% had no previous screening, 46% were of a racial/ethnic minority group, 22% had a 
family history of cancer, and 13% were rural residents. This project strengthened partnerships between health systems 
and local organizations.
Interpretation
An effective strategy for improving colorectal cancer screening rates, particularly among underserved populations, is to 
award health systems grants for implementing community-based screening events in conjunction with community 
partners.
Background
Colorectal cancer (CRC) is the fourth most commonly diagnosed cancer in Wisconsin and the second leading cause of 
cancer-related death (1). Statewide incidence and mortality rates for CRC vary by race and ethnicity; African 
Americans, American Indians, and certain Asian populations are more likely than whites to develop this disease and 
die from it (2). CRC disparities are related to the effect geography and socioeconomic status have on obtaining proper 
cancer screenings. Rural, low-income, and uninsured people are less likely to receive and be up-to-date with CRC 
screening (3,4).
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CRC screening guidelines recommend a regular fecal occult blood test, sigmoidoscopy, or colonoscopy from age 50 
until age 75; however, less than two-thirds of Americans aged 50 or older follow those recommendations (5,6).
More than 30% of eligible Wisconsin adults have never had a colonoscopy or sigmoidoscopy (7). Survival rates for CRC 
can exceed 90% if diagnosed early, yet over half of recent cases in Wisconsin were diagnosed at a regional or distant 
stage, indicating a need for earlier detection through improved screening programs (8).
The Wisconsin Comprehensive Cancer Control Program (WCCCP) works to engage public, private, and community 
partners to implement a statewide approach to cancer control (9). To examine possibilities for improving CRC 
screening statewide, WCCCP convened a stakeholder group, the Wisconsin Colorectal Cancer Screening Taskforce, 
which analyzed county-level screening rates and assessed current screening capacity. Those results guided the 
subsequent development of a grant application to fund health systems’ development of CRC screening events for 
underserved Wisconsin communities.
From 2010 through 2012, WCCCP awarded grants to 5 regional health systems for the purpose of planning and 
implementing CRC screening events. Health systems and community partners designated underserved populations in 
their service areas and then designed events to maximize participation for those attendees.
Community Context
Wisconsin is a geographically varied state that includes urban, rural, and tribal areas. Although most of the state’s 
population is non-Hispanic white, there are regional concentrations of racial and ethnic minorities: 6.5% African 
American, 6.1% Hispanic or Latino, 2.4% Asian (33% of whom are Hmong), and 1.1% American Indian (10).
Disparities in CRC incidence and mortality between African Americans and whites in Wisconsin are large and 
worsened between 1995 and 2006 (11). Low socioeconomic status is associated with higher incidence of and poorer 
survival from CRC, and 12% of Wisconsin’s population lives below the poverty line (10,12). Nearly one-third of 
Wisconsinites also live in rural areas, where cancer screening and early detection services are frequently underused 
(13,14). In 2009, WCCCP conducted an endoscopic capacity assessment in Wisconsin and found that, although 
capacity to provide CRC screening to all residents of Wisconsin existed, distances, cost, and time from work were 
barriers to receiving cancer screenings for rural residents (14).
The objective of WCCCP’s CRC screening grants program was to reduce disparities by increasing CRC screening rates 
in underserved populations in Wisconsin. Our community engagement objective was to strengthen partnerships 
between regional health care systems, community partners, and target populations in their communities. We hoped 
that as an outcome of our community engagement efforts, grantees’ experiences would serve as examples for other 
health systems interested in increasing CRC screening rates in underserved populations.
Methods
Our community-based grant program enabled Wisconsin health systems and their community partners to develop and 
implement new CRC screening events for underserved populations in their respective service areas. We chose to use 
this partner approach to engage target populations because health systems have the technical capacity to offer 
screening and follow-up in a community setting, and local community partners understand the targeted populations 
and can offer grassroots outreach. Community–clinical partnerships are an essential element of this program.
WCCCP awarded grants to 5 health care systems with access to target populations whose demographic, geographic, or 
economic characteristics limit their access to CRC screening services. System A and System B are both urban-based 
health systems that serve a large number of African American and uninsured patients. System C spans a small city and 
surrounding rural geographic area containing a large immigrant Hmong community, and System D is a suburban 
health system that primarily serves a single county with many rural and Hispanic residents. System E is a rural, 
federally qualified health center (FQHC) (Table 1).
Applications for this funding opportunity were solicited via several channels: an e-mail listserv, monthly newsletters, 
and direct recruitment by program staff. Applicants were asked to clearly identify a target population for their 
proposed event or events and explain the need for increased CRC screening. Preference was given to proposals that 
included access to free screenings for uninsured or underinsured populations. Applicants designated an institutional 
planning team, led by a screening event coordinator. Grant applications also included a budget, a timeline for 
implementation, and an evaluation plan.
Another important aspect of the application process was identification of community partners: local organizations or 
leaders outside of each health system who would be able to help with participant recruitment and event design and 
implementation. Health systems selected their own community partner or partners. The selection was made on the 
basis of past partnerships with the community partner. WCCCP reviewed applications for community partners’ 
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commitment to the proposed event and successful previous engagement in cancer screening efforts. Finally, a CRC 
screening event requires staff to organize the event, a facility where the screening will occur, screening kits, access to 
patients, CRC educational materials, and capacity for follow-up with participants. Our grantees and their community 
partners were able to secure all of these additional resources.
Within 6 months of receiving funding, each award recipient was expected to develop and implement 1 or more CRC 
screening events. Grantees could create free-standing events or integrate screening activities into an existing event. 
Because of Centers for Disease Control and Prevention (CDC) regulations, grant money could not be used for direct 
patient services; all participating health care systems were therefore required to provide CRC screening test kits and 
documentation of available funds for additional diagnosis in case of a positive screening result in an uninsured or 
underinsured patient. All the participating health systems chose to offer immunochemical fecal occult blood tests 
(iFOBTs) as their screening method at their events. On the basis of published data, a 3% positive FOBT rate was 
anticipated (15).
The CRC screening events were conducted in 2 phases. Phase I began in October 2010. Throughout, grantees shared 
their progress by submitting monthly planning meeting minutes. Grantees were also required to participate in monthly 
teleconference calls to discuss progress and challenges. Events were advertised by using various promotional media 
developed in conjunction with community partners, including clinic-based flyers, mailed postcards, and Spanish-
language radio ads. Most Phase I events took place in March 2011.
All grantees participated in process and outcome evaluations of their event or events. Evaluation methods used 
included event observations, interviews with key health system staff and their community partners, and screening 
forms that participants completed when they received their screening kit. Health systems also participated in monthly 
calls to discuss the planning process and completed final reports for both Phases I and II. WCCCP provided each of the 
grantees with a summary of Phase I evaluation results, including a “menu of ideas” for how they might improve future 
events. Phase I grantees were encouraged to tailor their original strategies on the basis of lessons learned and to apply 
for another round of funding.
Four of the 5 original grantees submitted applications and received funding in Phase II, which began in October 2011. 
The main purpose of Phase II was to refine previous events and test new ideas to bring community partners and health 
systems together to reach underserved populations with CRC screening. Most events in Phase II were held in February 
and March of 2012.
Our final project evaluation was based on multiple objectives: maximum community participation at events through 
increased CRC screening and the creation of community–clinical partnerships. WCCCP employed both process and 
outcome evaluation methods and collaborated with an external evaluator to review and synthesize evaluation data into 
2 final reports. At the conclusion of each grant phase, the evaluator used qualitative and quantitative data to 
summarize the event planning process.
We collected information from individual event sites to learn as much about the implementation process as possible. 
Our evaluator created a database for grantees to track patients who received test kits at screening events. To track 
community representation, registration sheets at each event asked for demographic characteristics of the person being 
offered CRC screening. Additionally, either the external evaluator or WCCCP staff attended at least 1 of each grantee’s 
events and conducted an onsite observational assessment. We created a brief Internet survey for community partners’ 
representatives to solicit partnership ratings and comments for improvement, which received 27 responses — each of 
the 5 health systems recruited 1 or more community partners, and sometimes multiple people represented the 
community partners (16 from Phase I and 11 from Phase II). We also conducted telephone interviews with 2 additional 
partners who preferred that format for feedback. All but 2 community partners’ representatives stated they would 
definitely collaborate with a health system on future events. Several representatives provided ideas for other health-
related events they would like to see in their areas.
Outcomes
The health systems in our grant program offered 36 CRC screening events in Phase I and II from 2010 through 2012; 
System A, which only participated in Phase I, did an evening presentation to participants in the Wisconsin Well 
Woman Program (the state’s National Breast and Cervical Cancer Early Detection Program), and Systems B and C also 
did events with the Wisconsin Well Woman Program participants in Phase II. System B also staffed 14 outreach booths 
at their urban clinics in Phase I. In Phase I, System C did 6 community health events, including 1 booth at an annual 
community health fair for Hmong elders. In Phase II, health systems focused on just 2 events: a booth at the Hmong 
Elder health fair and the Wisconsin Well Woman Program event. System D did a Hispanic cancer prevention fair held 
at a hospital in both Phases I and II. System E held 2 events for school district staff and an outreach booth at a health 
mission for Phase I, and in Phase II they had outreach booths at 5 previously scheduled country agricultural extension 
events (Table 2). CRC screening kits were distributed at all of the events. All of these events were new or the screening 
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component of the event was new, and the 5 health systems did not distribute iFOBT kits to these populations before 
this effort. Overall, systems differed in their approaches to planning and implementation, and resulting events varied 
widely in terms of number of screening kits distributed, percentage returned, and percentage testing positive for 
abnormalities.
With the primary goals of the grant project in mind, 3 key outcomes were assessed: event participation by members of 
underserved communities, distribution and return of CRC screening test kits, and effectiveness of community–clinical 
partnerships.
Event participation by underserved communities
Our program resulted in the distribution of more than 600 iFOBT kits to underserved Wisconsin residents. Of all event 
attendees who received test kits (n = 633), 63% reported that they were uninsured or underinsured, 55% had no 
previous screening, 46% belonged to a racial/ethnic minority group, 22% reported a family history of cancer, and 13% 
were rural residents (Figure 1). Most of those reached had not been offered screening otherwise.
Figure 1. Sociodemographic characteristics of eligible Wisconsin adults screened for colorectal cancer in conjunction 
with the Wisconsin Comprehensive Cancer Control Program screening events grant project, as a percentage of the 
total number offered screening. Participants (n = 633) may be counted in more than 1 category. [A tabular version of 
this figure is also available.]
Distribution and return of CRC screening test kits
Our program contributed to an increase in CRC screening in the underserved populations in the catchment areas of the 
participating health systems. The 36 screening events we funded enabled the distribution of 633 CRC screening kits to 
a range of underserved community members throughout Wisconsin. Of those kits, 506 (80%) were returned to local 
health systems. These return rates are higher than what has been reported previously in the literature (25%–63%) (16–
18). Sites that used both incentives and follow-up calls had the highest return rates. Fifty-seven (9%) of the returned 
iFOBTs tested positive for colorectal abnormalities, which was higher than the initial estimate of 3% (15) (Figure 2). Of 
the 57 who tested positive, all but 5 were able to be reached and given further diagnostic testing and care as needed. 
The database created by our external evaluator, which included contact information for the iFOBT kit recipients, made 
it easier for health systems to track the distribution and return of screening test kits.
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Figure 2. Total fecal immunochemical blood test (iFOBT) kits distributed, returned, and testing positive for 
abnormalities in Phases I and II of the Wisconsin Comprehensive Cancer Control Program colorectal cancer screening 
events grant project. [A text description of this figure is also available.]
Effectiveness of community–clinical partnerships
Our program facilitated new and productive linkages between 5 major health systems and various community 
partners, including Hispanic and Hmong community resource networks, county agricultural extension offices, the 
American Cancer Society, the Wisconsin Well Woman Program, aging and disability centers, a veteran services office, a 
local school district, and low-income clinics. The high level of community partner participation in planning and 
implementing the various screening events (as measured in the community partner evaluation survey) is a reflection of 
grantees’ meaningful collaboration with relevant community partners. Furthermore, grantees’ and their community 
partners’ ongoing participation in our program evaluation process invited mutual reflection about how to strengthen 
community–clinical partnerships, resulting in a more concretely focused set of events in Phase II.
It was important for health systems and community partners to take time to learn how the other conducts its work and 
for both to assume responsibility for the event. Survey results from community partners indicated that it was helpful 
for health systems to find a balance between asking too much of the community partner and not collaborating enough 
or underusing community expertise for outreach. Events with more balanced clinical–community partnerships yielded 
higher participation, higher rates of return on screening tests, and better survey ratings from community partners.
Factors that facilitate efficient and effective CRC screening events
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The use of qualitative process evaluation, such as event observations, helped identify several factors that may influence 
the success of cancer screening events. For example, we observed that stand-alone screening events planned by health 
systems and community partners were the most effective type of venue for distributing test kits and ensuring their 
return. Grantees who changed to this type of event in Phase II felt that they were more efficient in reaching the target 
populations when they compared their approach with that in Phase I. One site gave out the same number of kits (n = 
71) in both phases of the project, but in Phase I, they did so with booths at 14 events versus holding a one-time stand-
alone event in Phase II. We also learned that return rates for test kits were generally highest when supported by follow-
up calls and incentives, such as a grocery or gas gift card or cash.
Challenges
Although this project generated many positive outcomes, there were some challenges. Follow-up on positive screening 
tests was not always easy. In Phase I, the Hmong community members we initially screened had a disproportionately 
high number of positive results, yet we were unable to reach most of those people for follow-up. Difficulty in reaching 
Hmong members with positive test results persisted in Phase II, when additional resources for interpreters were 
included. Additional research is needed to understand the reasons for higher positive rates among this population and 
to determine the most effective strategies for follow-up. Another issue in Phase I was that some systems struggled to 
secure resources for follow-up diagnostic testing (in cases of uninsured or underinsured patients with an initial 
positive iFOBT screening); we clarified this expectation in our Phase II application process, and applicants who were 
not able to provide advance guarantees of adequate support were excluded from participating in Phase II. We also 
observed that more resources may be required to reach rural participants since they are fewer in number and farther 
apart geographically.
Interpretation
We believe this grant program was worthwhile, because of its ability to galvanize community–clinical partnerships and 
reach underserved populations with much-needed cancer screening. Lessons learned from this program are relevant to 
health systems wanting to offer cancer screenings to underserved populations, particularly with regard to 
considerations such as event settings, community partnerships, participant recruitment, and follow-up.
Holding a stand-alone event enabled distribution of higher numbers of tests than adding events to a pre-existing 
forum. However, in rural areas, special events still need to be tested as venues for screening to ensure that the target 
audience will be in attendance and be receptive to getting screened.
The choice of setting also affects recruitment; for example, grantees reported that it took more time and planning than 
anticipated to get staff and patients involved in screenings at busy low-income clinics. In all settings, recruitment may 
be boosted by the use of promotional mailings. Sites that sent out personalized letters in advance of events had a 
strong, positive response from community members targeted for screening.
To improve the success of community–clinical partnerships, clear roles and responsibilities among the partners should 
be delineated from the start. Community partners bring their relationships and expertise to tailor programming to the 
needs of local populations, and health systems can contribute clinical resources and knowledge to support the 
implementation of quality care services.
Budgeting adequate staff time to follow up on positive screening tests is another important element of completing a 
successful screening project. In particular, members of underserved minority groups may require dedicated and 
culturally competent outreach to ensure that they receive notification of their test results and adequate diagnostic 
follow-up.
Awarding grants to health systems for the purpose of implementing community screening events was an effective 
strategy for improving rates of CRC screening in Wisconsin, particularly in underserved populations. This program 
strengthened partnerships between health care systems and local organizations, both of which have ongoing potential 
to benefit the partners and participants involved.
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Tables
Table 1. Summary of Wisconsin Health Systems Given Grants for Colorectal 
Cancer Screening Events, Targeted Local Populations, and Types of 
Community Partners Assisting With Event Planning and Implementation, 2010–
2012
Grantee System A System B System C System D System E
Health system 
characteristic















































organizations; local Well 
Woman Program office; 
local American Cancer 








Abbreviation: FQHC, federally qualified health center.
Table 2. Summary of All Colorectal Cancer Screening Events Developed by 
Participating Wisconsin Health Systems, With Screening Test Kit 
Distribution Totals, 2010–2012







Outreach booths at 
multiple clinics; 
special events for 
invited participants
Outreach booth at 
Hmong health event; 










Total no. of 
events
1 (phase I 
only)
17 8 2 8
Total no. of 
test kits 
distributed
105 143 77 257 51
Total no. of 
test kits 
returned
101 98 52 216 39
Incentives 
given to those 
who return kits
None $10 grocery gift card $5 gasgift card $15 cash $10 cash
Total no. of 
positive tests
7 6 5 33 6
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